Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
The effect of LY333531 on protein in the urine in patients with type 2 diabetes. Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on The effect of LY333531 on protein in the urine in patients with type 2 diabetes. conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. The effect of LY333531 on protein in the urine in patients with type 2 diabetes. Clinical research trials and The effect of LY333531 on protein in the urine in patients with type 2 diabetes. medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like The effect of LY333531 on protein in the urine in patients with type 2 diabetes.. The effect of LY333531 on protein in the urine in patients with type 2 diabetes. Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a The effect of LY333531 on protein in the urine in patients with type 2 diabetes. clinical trial. Participants frequently obtain the most expert healthcare available for their The effect of LY333531 on protein in the urine in patients with type 2 diabetes. condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "T" Clinical Trials Conditions > The effect of LY333531 on protein in the urine in patients with type 2 diabetes.

The effect of LY333531 on protein in the urine in patients with type 2 diabetes.



The effect of LY333531 on protein in the urine in patients with type 2 diabetes.

For Condition: Diabetic Nephropathy
Status: No longer recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: The purpose of this study are to determine 1) Whether Ly333531 can reduce uriniary albumin/creatinine excretion in patients with Type II diabetes and persistent albuminuria 2) Whether LY333531 reduces urinary TGF-B, 3) the safety of LY333531 and any side effects that may be associated with it.
Details:
Eligibility:
Study Type:
  Interventional, Treatment
Minimum Age/Maximum Age: 30 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Type 2 diabetes mellitus - Greater than or equal to 30 years of age - Albumin to Creatinine ratio (greater than 200 mg/g and less than 2000 mg/g) 4)Without language barrier. Exclusion Criteria: - Serum Creatinine greater than 2.0 mg/dl males or greater than 1.7 mg/dl females - B/P greater than 150 systolic and greater than 90 diastolic - Hemoglobin Alc greater than 11% - Liver Function Tests 2 times upper limit of normal - Poor medical or psychiatric risk.
Total Enrollment: 

Location and Contact Information:


Additional Information:
Study ID Numbers:
  6249; 
Study Start Date: 
Record last reviewed: July 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00044148

Other Diabetic Nephropathy Studies:
1. Pirfenidone: A New Drug to Treat Kidney Disease in Patients with Diabetes

2. Matrix metalloproteinases and Diabetic Nephropathy

3. Study of Drugs for High Blood Pressure and High Cholesterol in American Indians with Type 2 Diabetes at High Risk of Kidney or Heart Disease

4. The effect of LY333531 on protein in the urine in patients with type 2 diabetes.

5. Soy Protein in Early Diabetic Nephropathy

Related Studies:

Other Diabetic Nephropathy Clinical Trials
Other California Clinical Trials
Other Walnut Creek Clinical Trials

The effect of LY333531 on protein in the urine in patients with type 2 diabetes.

Modify your Search

  Other Diabetic Nephropathy Clinical Trials
  Other California Clinical Trials
  Other Walnut Creek Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103